Tokyo Tape
Sign in
← AuBEX

Half-year report · Q2

3583.TEDINET S100UOJ8
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥3.0bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥5.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥2.6bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥489m2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥270m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥454m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥601m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥294m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥452m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥294m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥302m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥436m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥218m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥302m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥218m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥9.6bnat 2024-09-30Cons.Assets
Total assets¥9.7bnat 2024-03-31Cons.Assets
Total assets¥9.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥3.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥3.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥6.5bnat 2024-09-30Cons.Net assets
Net assets / equity¥6.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥6.0bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥2.5bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.4bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥313m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥601m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥202m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥165m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥99m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥391m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥451m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥139m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥108.12024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥156.82023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.212023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio67.6%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio64.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥817m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥817m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥513,000
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥65m
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue2024-04-01 → 2024-09-30¥2.2bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue external2024-04-01 → 2024-09-30¥2.2bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentsegment profit2024-04-01 → 2024-09-30¥598m
—segment totalrevenue2024-04-01 → 2024-09-30¥3.0bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥3.0bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥513,000
—segment totalsegment profit2024-04-01 → 2024-09-30¥663m
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥3.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥513,000
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥663m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥721m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥720m
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥645,000
jpcrp040300-q2r_E00584-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥48m
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue2023-04-01 → 2023-09-30¥1.9bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.9bn
jpcrp040300-q2r_E00584-000Technological Productsreportable segmentsegment profit2023-04-01 → 2023-09-30¥382m
—segment totalrevenue2023-04-01 → 2023-09-30¥2.6bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥2.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥645,000
—segment totalsegment profit2023-04-01 → 2023-09-30¥430m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥645,000
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥430m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Other caPrior1YearInstant156792000JPY
Other caCurrentQuarterInstant119237000JPY
Allowance for doubtful accounts caPrior1YearInstant-746000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-738000JPY
Current assetsPrior1YearInstant6342964000JPY
Current assetsCurrentQuarterInstant6320618000JPY
Buildings and structuresPrior1YearInstant2978823000JPY
Buildings and structuresCurrentQuarterInstant2958223000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-1980316000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-2004530000JPY
Buildings and structures netPrior1YearInstant998507000JPY
Buildings and structures netCurrentQuarterInstant953693000JPY
Machinery equipment and vehiclesPrior1YearInstant3399055000JPY
Machinery equipment and vehiclesCurrentQuarterInstant3435319000JPY
Accumulated depreciation machinery equipment and vehiclesPrior1YearInstant-2947817000JPY
Accumulated depreciation machinery equipment and vehiclesCurrentQuarterInstant-3001312000JPY
Machinery equipment and vehicles netPrior1YearInstant451238000JPY
Machinery equipment and vehicles netCurrentQuarterInstant434006000JPY
LandPrior1YearInstant1457525000JPY
LandCurrentQuarterInstant1457525000JPY
Lease assets ppePrior1YearInstant213318000JPY
Lease assets ppeCurrentQuarterInstant211966000JPY
Accumulated depreciation lease assets ppePrior1YearInstant-151130000JPY
Accumulated depreciation lease assets ppeCurrentQuarterInstant-158286000JPY
Lease assets net ppePrior1YearInstant62187000JPY
Lease assets net ppeCurrentQuarterInstant53679000JPY
Construction in progressPrior1YearInstant43800000JPY
Construction in progressCurrentQuarterInstant37063000JPY
Other ppePrior1YearInstant567042000JPY
Other ppeCurrentQuarterInstant610368000JPY
Accumulated depreciation other ppePrior1YearInstant-517786000JPY
Accumulated depreciation other ppeCurrentQuarterInstant-537537000JPY
Other net ppePrior1YearInstant49256000JPY
Other net ppeCurrentQuarterInstant72830000JPY
Property plant and equipmentPrior1YearInstant3062514000JPY
Property plant and equipmentCurrentQuarterInstant3008798000JPY
Patent rightPrior1YearInstant7423000JPY
Patent rightCurrentQuarterInstant7895000JPY
Lease assets iaPrior1YearInstant3322000JPY
Lease assets iaCurrentQuarterInstant2959000JPY
Other iaPrior1YearInstant19981000JPY
Other iaCurrentQuarterInstant17737000JPY
Intangible assetsPrior1YearInstant30727000JPY
Intangible assetsCurrentQuarterInstant28593000JPY
Investment securitiesPrior1YearInstant131245000JPY
Investment securitiesCurrentQuarterInstant129114000JPY
Investments in capitalPrior1YearInstant130000JPY
Investments in capitalCurrentQuarterInstant130000JPY
Deferred tax assetsPrior1YearInstant95322000JPY
Deferred tax assetsCurrentQuarterInstant80530000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass